Data Foundry

Drug recalls 2014

Warfarin Sodium Tablets — Class III drug recall D-1584-2014

Terminated recall by Taro Pharmaceuticals U.S.A., Inc., reported 2014-09-24, distributed in CA, HI, IL, MS, NH, OH, TX. Failed Content Uniformity Specifications.

Recall numberD-1584-2014
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmTaro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, United States
Recall initiated2014-08-25
Classified2014-09-12
Reported by FDA2014-09-24
Terminated2018-05-18
DistributedCA, HI, IL, MS, NH, OH, TX
Quantity1,396 bottles
NDC51672-4027, 51672-4027-00, 51672-4027-01, 51672-4027-03, 51672-4027-07, 51672-4028, 51672-4028-00, 51672-4028-01, 51672-4028-03, 51672-4028-07, 51672-4029, 51672-4029-00, 51672-4029-01, 51672-4029-03, 51672-4029-07, 51672-4030, 51672-4030-00, 51672-4030-01, 51672-4030-03, 51672-4030-07, 51672-4031, 51672-4031-00, 51672-4031-01, 51672-4031-03, 51672-4031-07 and 18 more
Lot numbers149400, 149649
Expiration dates2016-01-20

Product

Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.

Reason for recall

Failed Content Uniformity Specifications.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1584-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.